Insights on the Pharmaceutical Plastic Packaging Global Market to 2025 - Polyethylene Terephthalate Expected to Witness Significant Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Plastic Packaging Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The Pharmaceutical Plastic Packaging Market is expected to witness a CAGR of 8.24% over the forecast period (2020 - 2025).

Demand for plastic packaging is witnessing significant growth from the pharmaceutical industry in the forecast period because of its unmatched ability to be form both flexible and rigid containers. Additional features that led increased adoption in pharma is barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, resistance to heat and flame, and extension of expiry dates.

Companies Mentioned

• Gerresheimer AG
• Amcor Limited
• Berry Plastics Group, Inc.
• Aptar Pharma
• O.Berk Company, LLC
• Alpha Packaging
• Graham Packaging Company
• COMAR, LLC
• Alpack Plastic Packaging
• Drug Plastics Group
• Plastipak Holdings, Inc.

Key Market Trends

Polyethylene Terephthalate (PET) Expected to Witness Significant Growth

It is expected that pharma packaging will shift towards more sustainable materials by moving away from the plastic, which the industry traditionally has been heavily dependent on for design and manufacturing. But, the industry would continue the application of polyethylene terephthalate (PET) owing to its capability of breaking down its molecular level back into PET.

• For instance, in March 2020, Amcor developed a new bottle to pack multivitamin. The material used for the same was post consumer regrind (PCR). PCR comprises recycled materials including PET beverage bottles used by the consumer and have been recycled to produce a new product.
• As of January 2020, Gerresheimer is also expected to further expand its operations in Asia via two plants in China and India to manufacture plastic primary packaging for pharmaceutical products. Such steps are undertaken in order to maintain a steady supply to pharma companies. The facilities cater to production of standard range of different containers and closures, PET bottles, eye droppers, nasal sprays, and vaporizers as well as multiple customizations.

North America Expected to Witness Significant Growth

North America is home to leading pharmaceutical companies in the world. The companies like Abott, Pfizer and Johnson and Johnson have their headquarters in the US and Canada with manufacturing facilities around the globe. These companies for many of their were catering to the US market from offshore manufacturing facilities where they packaged.

• But the COVID 19 pandemic has shown the downside of offshore manufacturing and the US government in its statement on 26 May 2020, emphasized onshore production of pharma drug's and soon going to bring "Buy American" order , which result in these big companies shifting the production of the key drugs back to US where they will also be packaged. This expected have a significant impact of plastic packaging market in the future.
• The United States will continue to be the largest national pharmaceutical plastic packaging market as its advanced drug-producing sector commercializes new sophisticated therapies with specialized packaging needs. Advances in pharmaceutical packaging in the country are focused on improving the barrier properties of the packaging material.
• As people are becoming more health conscious and adopting a healthy lifestyle in Canada, the sale of a pharmaceutical drug is increasing. This makes the sales of pharmaceutical plastic packaging products, such as solid containers, vials, pouches, etc. There is a need for constant innovation as stringent regulations by agencies, such as the FDA, require manufacturers to comply with stringent regulations while packaging drugs in the region.

Key Topics Covered:

1 INTRODUCTION

1.1 Study Assumptions and Market Definition

1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Demand For Rigid & Flexible Pharmaceutical Plastic Products

4.2.2 Development of Better and More Advanced Healthcare Infrastructure

4.3 Market Restraints

4.3.1 Regulations Restricting the Sale and Availability of Pharmaceutical Plastic Products

4.3.2 Fluctuations in Raw Material Cost Due to Suppliers Bargaining Power

4.4 Industry Value Chain / Supply Chain Analysis

4.5 Industry Attractiveness - Porter's Five Force Analysis

5 MARKET SEGMENTATION

5.1 By Raw Material

5.1.1 Polypropylene (PP)

5.1.2 Polyethylene Terephthalate (PET)

5.1.3 Low Density Polyethylene (LDPE)

5.1.4 High Density Polyethylene (HDPE)

5.1.5 Other Types of Materials

5.2 By Product Type

5.2.1 Solid Containers

5.2.2 Dropper Bottles

5.2.3 Nasal Spray Bottles

5.2.4 Liquid Bottles

5.2.5 Oral Care

5.2.6 Pouches

5.2.7 Vials & Ampoules

5.2.8 Cartridges

5.2.9 Syringes

5.2.10 Caps & Closures

5.2.11 Other Product Types

5.3 Geography

5.3.1 North America

5.3.1.1 United States

5.3.1.2 Canada

5.3.2 Europe

5.3.2.1 United Kingdom

5.3.2.2 Germany

5.3.2.3 France

5.3.2.4 Spain

5.3.2.5 Italy

5.3.2.6 Rest of Europe

5.3.3 Asia-Pacific

5.3.3.1 China

5.3.3.2 India

5.3.3.3 Japan

5.3.3.4 Rest of Asia-Pacific

5.3.4 Latin America

5.3.4.1 Brazil

5.3.4.2 Argentina

5.3.4.3 Mexico

5.3.4.4 Rest of Latin America

5.3.5 Middle East & Africa

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET

For more information about this report visit https://www.researchandmarkets.com/r/e6cp43